About Oxford Cardiovascular Science
Researchers across Oxford are working together at the forefront of cardiovascular science, with the overall goal of translating discoveries from the laboratory though to clinical practice. Our researchers will apply new cross cutting technologies to develop cardiovascular imaging and phenotyping, drug development, cardiac computer modelling and stem cell & gene therapy.
We have outstanding experience in conducting clinical trials and epidemiological studies as well as state-of-the-art basic science and clinical research facilities. We are particularly proud of our ability to bring together molecular, epidemiological and physiological research to understand cardiac and vascular disease right from the molecular level all the way up to the wider population.
The British Heart Foundation is a key sponsor of cardiovascular research in Oxford and their two research centres offer scientists across the city fantastic opportunities for research & training, supporting the current and next generation of leaders in Cardiovascular Science.
11 October 2020
Professor Paul Riley will lead the scientific vision of the first institute of its kind in the world to physically merge the disciplines of developmental biology and regenerative medicine in a common goal to treat some of the world’s most prolific diseases.
Tuesday, 03 November 2020, 1.30pm to 5.15pm @ The meeting will be via Zoom
Tuesday, 15 June 2021 to Wednesday, 16 June 2021, 1pm - 4pm @ Imperial College, South Kensington Campus, London